While our EU partners are certified, GHM will start the process of certification under the Good manufacturing practice (GMP). This helps to ensure that products are consistently produced according to the highest quality standards. GMP is designed to minimize the risks involved in the entire pharmaceutical production chain rather than simply testing the final product (WHO).

GHM Genetic Development and its partners follow the guidelines for good agricultural and collection practices (GACP) for medicinal plants developed by the WHO. This provides transparency and traceability in the cultivation and breeding process.

Our partners practice Good Distribution Practice (GDP) according to the guidelines described by the WHO. These guidelines form the quality control system for the storage, sale and distribution of medicinal products for human use.

With our partner Green House DRC we have a government-licensed outdoor grow facility for the production of new plant genetics, raw plant material and crude plant extracts on an industrial scale.

Continuous quality control is crucial to the development and production of medicine and food supplements. We routinely check our crops, crude extracts and formulated products for their cannabinoid profiles and contaminants such as pesticides or microbes to ensure our products meet the highest quality standards.